Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin SR vs Levofloxacin for Acute Bacterial Maxillary Sinusitis
NCT00643409Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jan 2003
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 3 trial of azithromycin in Acute Bacterial Maxillary Sinusitis (ABMS), sponsored by Pfizer. Started Jan 2003; status: completed.
02
Drugs
azithromycin
03
Conditions
Acute Bacterial Maxillary Sinusitis (ABMS)
Beyond the preview
Go deeper on NCT00643409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00643409.